Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · August 28, 2019

Real-World 10-Year Experiences With Intravitreal Anti-VEGF Treatment for Neovascular AMD

Acta Ophthalmologica

 

Additional Info

Acta Ophthalmologica
Real-World 10-Year Experiences With Intravitreal Treatment With Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
Acta Ophthalmol 2019 Jul 08;[EPub Ahead of Print], T Brynskov, IC Munch, TM Larsen, L Erngaard, TL Sørensen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading